Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 1/Phase 2)
Cognition (Phase 3)
Cystic Fibrosis (Phase 1)
Geographic Atrophy (Phase 2)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hodgkin Disease (Phase 1/Phase 2)
Insulin Resistance (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)
Lymphoma, Follicular (Phase 1/Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 1/Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1/Phase 2)
Lymphoma, Mantle-Cell (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 1/Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Macular Degeneration (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasms (Phase 3)
Neuroblastoma (Phase 2)
Obesity (Phase 2)
Ovarian Neoplasms (Phase 2)
Precancerous Conditions (Phase 3)
Prostatic Neoplasms (Phase 2)
Psychotic Disorders (Phase 3)
Schizophrenia (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue